Abstract
The objective of this article is to review genotoxicologic and carcinogenic profile of the artificial sweetener aspartame. Aspartame is a synthetic dipeptide, nearly 180–200 times sweeter than sucrose. It is the most widely used artificial sweetener especially in carbonated and powdered soft drinks, beverages, drugs and hygiene products. There is a discussion ongoing for many years whether aspartame posses genotoxic and carcinogenic risk for humans. This question led to many studies to specify the adverse effects of aspartame. Therefore, we aimed to review the oldest to latest works published in major indices to gather information within this article. With respect to published data, genotoxicity and carcinogenicity of aspartame is still confusing. So, consumers should be aware of the potential side effects of aspartame before they consume it.
Similar content being viewed by others
References
Abd Elfatah AAM, Ghaly IS, Hanafy SM (2012) Cytotoxic effects of aspartame (diet sweet) on the histological and genetic structures of female albino rats and their offspring. Pak J Biol Sci 15:904–918
Abhilash M, Sauganth Paul MV, Mathews V, Varghese RHN (2013) Long-term consumption of aspartame and brain antioxidant defense status. Drug Chem Toxicol 36:135–140
Alleva R, Borghi B, Santarelli L, Strafella E, Carbonari D, Bracci M, Tomasetti M (2011) In vitro effect of aspartame in angiogenesis induction. Toxicol In Vitro 25:286–293
Alsuhaibani ES (2010) In vivo cytogenetic studies on aspartame. Comp Funct Genomics. Article ID 605921:1–4
Andreatta MM, Muñoz SE, Lantieri MJ, Eynard AR, Navarro A (2008) Artificial sweetener consumption and urinary tract tumors in Cordoba, Argentina. Prev Med 47:136–139
Anonymous (2013a) Information about aspartame. http://www.aspartameresource.com/pdf/aspartame_brochure.pdf. 04 Nov 2013
Anonymous (2013b) Aspartame intake. http://www.aspartameresource.com/intake.html. 04 Nov 2013
Anonymous (2013c) How much aspartame is it safe to consume? http://www.efsa.europa.eu/en/faqs/faqaspartame.htm#4. 04 Nov 2013
Bandyopadhyay A, Ghosha S, Mukherjee A (2008) Genotoxicity testing of low-calorie sweeteners: aspartame, acesulfame-K, and saccharin. Drug Chem Toxicol 31:447–457
Bosetti C, Gallus S, Talamini R, Montella M, Franceschi S, Negri E, La Vecchia C (2009) Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy. Cancer Epidemiol Biomarkers Prev 18:2235–2238
Bright G (1999) Low-calorie sweeteners-from molecules to mass markets. World Rev Nutr Diet 85:3–9
Dearfield KL, Cimino MC, McCarroll NE, Mauer I, Valcovic LR (2002) Genotoxicity risk assessment: a proposed classification strategy. Mutat Res 521:121–135
Gurney JG, Pogoda JM, Holly EA, Hecht SS, Preston-Martin S (1997) Aspartame consumption in relation to childhood brain tumor risk: results from a case–control study. J Natl Cancer Inst 89:1072–1074
Hagiwara A, Fukushima S, Kitaori M, Shibata M, Ito M (1984) Effects of three sweeteners on the rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gann 75:763–768
Ishii H (1981) Incidence of brain tumors in rats fed aspartame. Toxicol Lett 7:433–437
Jeffrey AM, Williams GM (2000) Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay. Food Chem Toxicol 38:335–338
Jouyban A, Parsa H (2012) Genotoxic impurities in pharmaceuticals, toxicity and drug testing, Prof. Bill Acree (ed), ISBN: 978-953-51-0004-1, InTech. http://www.intechopen.com/books/toxicity-and-drug-testing/genotoxic-impurities-in-pharmaceuticals
Kamath S, Vijaynarayana K, Prashanth Shetty D, Shetty P (2010) Evaluation of genotoxic potential of aspartame. Pharmacologyonline 1:753–769
Kashanian S, Khodaei MM, Kheirdoosh F (2013) In vitro DNA binding studies of aspartame, an artificial sweetener. J Photochem Photobiol B Biol 120:104–110
Lean MEJ, Hankey CR (2004) Aspartame and its effects on health. BMJ 329:755–756
Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, Campbell D, Hollenbeck AR, Schatzkin A (2006) Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev 15:1654–1659
Lok KY-W, Chung W-Y, Iris FF (2010) Colour additives in snack foods consumed by primary school children in Hong Kong. Food Addit Contam 3:148–155
Molinary SV (1978a) An evaluation of mutagenic potential employing the Ames Salmonella/microsome assay. (Safety Assessment Project Number 1377). G.D. Searle & Co.
Molinary SV (1978b) An evaluation of mutagenic potential employing the Ames Salmonella/microsome assay. (Safety Assessment Project Number 1378). G.D. Searle & Co.
Molinary SV (1984) Preclinical studies of aspartame in nonprimate animals. In: Stegink LD, Filer LJ Jr (eds) Aspartame physiology and biochemistry. Marcel Dekker, New York, pp 289–306
Mukhopadhyay M, Mukherjee A, Chakrabarti J (2000) In vivo cytogenetic studies on blends of aspartame and acesulfame-K. Food Chem Toxicol 38:75–77
Olney JW, Farber NB, Spitznagel E, Robins LN (1996) Increasing brain tumors rates: is there a link to aspartame? J Neuropathol Exp Neurol 55:1115–1123
Rangan C, Barceloux DG (2009) Food additives and sensitivities. Dis Monogr 55:292–311
Rencüzoğulları E, Tüylü BA, Topaktaş M, İla HB, Kayraldız A, Arslan M, Budak Diler S (2004) Genotoxicity of aspartame. Drug Chem Toxicol 27:257–268
Robinson DI (2010) Control of genotoxic impurities in active pharmaceutical ingredients: a review and perspective. Org Process Res Dev 14:946–959
Sargentini NJ, Smith KC (1986) Mutagenesis by normal metabolites in Escherichia coli: phenylalanine mutagenesis is dependent on error-prone DNA repair. Mutat Res 161:113–118
Sasaki YF, Kawaguchi S, Kamaya A, Ohshita M, Kabasawa K, Iwama K, Taniguchi K, Tsuda S (2002) The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat Res 519:103–119
Schernhammer ES, Hu F, Giovannucci E, Michaud DS, Colditz GA, Fuchs C (2005) Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev 14:2098–2105
Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D (2012) Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr 96:1419–1428
Schwartz GR (1999) Aspartame and breast and other cancers. West J Med 171:300–301
Shephard SE, Wakabayashi K, Nagao M (1993) Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation. Food Chem Toxicol 31:323–329
Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A (2006) First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague–Dawley rats. Environ Health Perspect 114:379–385
Weihrauch MR, Diehl V (2004) Artificial sweeteners—do they bear a carcinogenic risk? Ann Oncol 15:1460–1465
Whitehouse CR, Boullata J, McCauley LA (2008) The potential toxicity of artificial sweeteners. AAOHN J 56:251–259
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yılmaz, S., Uçar, A. A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not?. Cytotechnology 66, 875–881 (2014). https://doi.org/10.1007/s10616-013-9681-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-013-9681-0